Frontier Medicines Corporation
Latest round
- Series C
Last raised
- Jun 2024
Total raised
- $256M
Investors
- 11
About Frontier Medicines Corporation
Based in California, US, and founded in 2018 by CEO Chris Varma and Daniel Nomura, Frontier Medicines Corporation operates as a biopharmaceutical company that utilizes chemoproteomics to discover and develop therapies that target the binding pockets on proteins and enable them to be accessible for therapeutic intervention. Frontier Medicines focuses on developing precision-based treatments with an initial emphasis on oncology. The company’s primary product is a dual KRASG12C inhibitor, designed to target both active and inactive forms of the KRAS mutation. The firm’s approach integrates advanced scientific techniques, including chemoproteomics and machine learning, to build a precision pipeline of medicines. This pipeline aims to address specific cancer-related mutations, improving treatment efficacy and patient outcomes. Frontier Medicines operates from offices in South San Francisco and Boston, supporting their research and development efforts.
Who invested in Frontier Medicines Corporation
11 investors across 5 rounds
See all investors in Frontier Medicines Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Frontier Medicines Corporation
Who invested in Frontier Medicines Corporation?
Frontier Medicines Corporation has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Frontier Medicines Corporation raised?
Frontier Medicines Corporation has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Frontier Medicines Corporation last raise money?
Frontier Medicines Corporation's most recent round on record is a Series C, in Jun 2024.
What does Frontier Medicines Corporation do?
Based in California, US, and founded in 2018 by CEO Chris Varma and Daniel Nomura, Frontier Medicines Corporation operates as a biopharmaceutical company that utilizes chemoproteomics to discover and develop therapies that target the binding pockets on proteins and enable them to be accessible for therapeutic intervention.
Where is Frontier Medicines Corporation headquartered?
Frontier Medicines Corporation is headquartered in South San Francisco, US.
Which VCs invest in companies like Frontier Medicines Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Frontier Medicines Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Frontier Medicines Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.